Please use this identifier to cite or link to this item:
|Title:||The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells|
|Authors:||GONÇALVES SILVA ISABEL; YASINSKA INNA M.; SAKHNEVYCH SVETLANA S.; FIEDLER WALTER; WELLBROCK JASMIN; BARDELLI MARCO; VARANI LUCA; HUSSAIN ROHANAH; SILIGARDI GIULIANO; CECCONE GIACOMO; BERGER STEFFEN M.; USHKARYOV YURI A.; GIBBS BERNHARD F.; FASLER-KAN ELIZAVETA; SUMBAYEV VADIM|
|Citation:||EBIOMEDICINE vol. 22 p. 44-57|
|Publisher:||ELSEVIER SCIENCE BV|
|Type:||Articles in periodicals and books|
|Abstract:||Acutemyeloid leukemia (AML) is a severe and often fatal systemicmalignancy. Malignant cells are capable of escaping host immune surveillance by inactivating cytotoxic lymphoid cells. In this work we discovered a fundamental molecular pathway, which includes ligand-dependent activation of ectopically expressed latrophilin 1 and possibly other G-protein coupled receptors leading to increased translation and exocytosis of the immune receptor Tim-3 and its ligand galectin-9. This occurs in a protein kinase C and mTOR (mammalian target of rapamycin)-dependent manner. Tim-3 participates in galectin-9 secretion and is also released in a free soluble form. Galectin-9 impairs the anti-cancer activity of cytotoxic lymphoid cells including natural killer (NK) cells. Soluble Tim-3 prevents secretion of interleukin-2 (IL-2) required for the activation of cytotoxic lymphoid cells. These results were validated in ex vivo experiments using primary samples from AML patients. This pathway provides reliable targets for both highly specific diagnosis and immune therapy of AML.|
|JRC Directorate:||Health, Consumers and Reference Materials|
Files in This Item:
There are no files associated with this item.
Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.